000 | 01304 a2200397 4500 | ||
---|---|---|---|
005 | 20250513075833.0 | ||
264 | 0 | _c19930211 | |
008 | 199302s 0 0 eng d | ||
022 | _a0091-3952 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHughes, A J | |
245 | 0 | 0 |
_aThe clinical features of Parkinson's disease in 100 histologically proven cases. _h[electronic resource] |
260 |
_bAdvances in neurology _c1993 |
||
300 |
_a595-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlzheimer Disease _xdrug therapy |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
650 | 0 | 4 |
_aDementia _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xadverse effects |
650 | 0 | 4 |
_aLewy Bodies _xultrastructure |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeurofibrillary Tangles _xultrastructure |
650 | 0 | 4 |
_aNeurologic Examination _xdrug effects |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 |
_aParkinson Disease, Secondary _xdrug therapy |
650 | 0 | 4 | _aTissue Donors |
700 | 1 | _aDaniel, S E | |
700 | 1 | _aLees, A J | |
773 | 0 |
_tAdvances in neurology _gvol. 60 _gp. 595-9 |
|
999 |
_c8419469 _d8419469 |